Skip to main content
Log in

Effect of lithium treatment on the GH-clonidine test in affective disorders

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The effects of short-term lithium (Li) administration on α2-adrenoceptor sensitivity was studied in 10 healthy volunteers and in 15 patients with normothymic, phasic depressive disorders. The GH-clonidine test was used to examine α2-adrenoceptor sensitivity, administered before and after Li treatment (600 mg/day for 7 days in controls and for 15 days in patients). Before treatment, the GH response to clonidine in the patients was blunted, and afterwards it tended to increase in the patients and it was significantly decreased in the controls. The difference between the response in the two groups was significant and was correlated both with the diagnosis and the pretreatment GH response to the stimulus.

The opposing pattern of the response in patients and controls to Li administration suggests that the drug exerts a modulatory effect on α2-adrenoceptor sensitivity, with up or down regulation inversely correlated with pretreatment status.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Boyer P, Dàvila M, Dchaub C, Nassiet J (1986) Growth hormone response to clonidine stimulation in depressive states. Psychiatr Psychobiol 1: 189–196

    Google Scholar 

  • Brambilla F, Catalano M, Lucca A, Smeraldi E (1988a) Clonidine-induced growth hormone release. In: Johnson FN (ed) Lithium and the endocrine system. Karger, Basel

    Google Scholar 

  • Brambilla F, Catalano M, Lucca A, Della Maggiora P, Smeraldi E (1988b) GH response to clonidine stimulation in affective disorders: Effects of lithium therapy. Proc Int Conference on “New directions in affective disorders”. Jerusalem-Israel 5–9 April 1987 (in press)

  • Catalano M, Bellodi L, Lucca A, Brambilla F (1984) Lithium and α2-adrenergic receptors: Effects of lithium ion on clonidine-induced growth hormone release. Neuroendocrinol Lett 6: 61–65

    Google Scholar 

  • Charney DS, Heninger GR, Sternberg DE, Hafstadt KM, Giddings S, Landis DH (1982) Adrenergic receptor sensitivity in depression. Arch Gen Psychiatry 39: 290–294

    Google Scholar 

  • Checkley SA, Slade AP, Shur E (1982) Growth hormone and other responses to clonidine in patients with endogenous depression. Br J Psychiatry 138: 51–55

    Google Scholar 

  • Checkley SA, Arendt J (1984) Pharmacoendocrine studies of GH, PRL and melatonin in patients with depressive illness. In: Brown GM, Koslow SH, Reichlin S (eds) Neuroendocrinology and psychiatric disorder. Raven Press, New York

    Google Scholar 

  • Erikson E (1985) Experimental psychoneuroendocrinology: Brain α2-adrenoceptor function and growth hormone release. Medi-Press, Goteborg

    Google Scholar 

  • Frazer A (1979) Determination of the lithium ratio of human erytrocytes in vivo. In: Cooper TB, Gershon S, Kline NS, Schou M (eds) Lithium: Controversies and unresolved issues. Excerpta Medica, Amsterdam

    Google Scholar 

  • Gruen PH (1978) Endocrine changes in psychiatric diseases. Med Clin North Amer 62: 285–296

    Google Scholar 

  • Kafka MS, Wirz-Justice A, Naber D, Marangos PJ, O'Donohue TL, Wehr TA (1982) Effect of Lithium on circadian neurotransmitter receptor rhythms. Neuropsychobiology 8: 41–45

    Google Scholar 

  • Matussek N, Ackeneil M, Hippius H, Muller F, Schroder HTh, Schultes H, Wasilewski B (1980) Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiatry Res 2: 25–36

    Google Scholar 

  • Rosenblatt JE, Pert CB, Tallman JF, Pert A, Bunney WE Jr (1979) The effect of imipramine and lithium on α- and β-receptor binding in rat brain. Brain Res 160: 186–195

    Google Scholar 

  • Siever LJ, Uhde TW, Silberman EK, Lake CR, Jimerson DC, Risch SC, Kalin NH, Murphy DL (1982) Evaluation of alphaadrenergic responsiveness to clonidine challenge and noradrenergic metabolism in the affective disorders and their treatment. Psychopharmacol Bull 18: 118–119

    Google Scholar 

  • Siever LJ, Pickar D, Lake CR, Cohen RM, Uhde TW, Murphy DL (1983) Extreme elevations in plasma norepinephrine associated with decreased α-adrenergic responsivity: Two case reports. J Clin Psychopharmacol 3: 39–41

    Google Scholar 

  • Trieser S, Kellar KJ (1979) Lithium effects on adrenergic receptor supersensitivity in rat brain. Eur J Pharmacol 58: 85–86

    Google Scholar 

  • Wolf MA (1978) Present hypotheses on the mechanism of lithium action. 1. Lithium and neuromediators. 2. Lithium and membrane. From the receptor to the cyclic nucleotide by way of membrane phospholipids. L'Encephale 13: 3–22

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brambilla, F., Catalano, M., Lucca, A. et al. Effect of lithium treatment on the GH-clonidine test in affective disorders. Eur J Clin Pharmacol 35, 601–605 (1988). https://doi.org/10.1007/BF00637595

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00637595

Key words

Navigation